Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Social Media Screening for ADR-monitoring – Like it or not!

Posted on December 16th, 2015 by

Pharmacovigilance

Social Media and Pharmacovigilance

Limitations of clinical trials and traditional post-marketing sources of safety information. 

Due to limitations of pre-marketing clinical trials, there isn’t much information available once a medicinal product is authorized for marketing. (more…)

Are we expecting too much from the EMA’s MLM service?

Posted on December 16th, 2015 by

Pharmacovigilance

ema logo
At the beginning of September 2015, the EMA launched the Medical Literature Monitoring (MLM) service. I recently read the EMA’s MLM launch phase closure report in addition to information from a recent EMA information day and have highlighted some key points below. (more…)

Propelling tomorrow’s chemistry stars

Posted on December 14th, 2015 by

Chemistry

Creative designers clapping their hands in a bright office

After years of hard work, late nights and hours of toil in the lab, the sought after chemistry PhD can aid young scientists towards a successful career. In such a competitive setting, it’s vital to make sure you stand out as a researcher from the start. (more…)

Are We Silently Suffering from Chemophobia?

Posted on December 4th, 2015 by

Chemistry

Help-Remedies-3

As a chemist you work with chemical compounds every day studying, mixing, separating, modifying. You know that we are made up of chemicals, and that if we zoom in close enough we will be visible as clusters of proteins, lipids, sugars, some metals and nonmetals. (more…)

Taxonomy to answers

Posted on December 1st, 2015 by

Pharma R&D

turtle

What is a Taxonomy?
A taxonomy is a system to classify objects or concepts. We all use such systems to bring order into different aspects of our lives, be it food in the refrigerator, clothes in the closet or files on our laptops. (more…)

French ePharmaDay 2015: New EU Clinical Trial Regulation and Data Transparency

Posted on November 24th, 2015 by

Pharmacovigilance

top_epharma

On 16 April 2014, the new EU Clinical Trial Regulation on medicines for human use was adopted. The purpose of the new Clinical Trial Regulation is to create an environment that is favourable for conducting clinical trials, with the highest standards for patient safety, within the EU. (more…)

  1. 1
  2. …
  3. 65
  4. 66
  5. 67
  6. 68
  7. 69
  8. 70


About this Blog

iStock_000019748868_Full

The Elsevier Pharma R&D blog provides insight and opinion on topics related to pharmaceutical research and development, namely: big data, target identification, new drug discovery, drug safety monitoring, risk mitigation and regulatory compliance. We serve the community of chemists, scientists, drug safety specialists, educators and students interested in pharmaceutical R&D.

Editor’s note: The views and opinions expressed are those of the author and do not necessarily reflect the views of Elsevier,  its affiliates and sponsors or its parent company, Reed Elsevier.